Medical News

RSS

Orthocell presents positive data for Ortho-ATI and Ortho-ACI in patients with damaged cartilage, tendon injuries

Regenerative medicine company Orthocell Limited is pleased to announce it has held its inaugural user group meeting in Sydney.

11 Aug 2015

Gastric bypass surgery enhances energy expenditure, leads to sustained weight loss

Gastric bypass surgery often leads to a sustained weight loss. Researchers at Sahlgrenska Academy have found part of the explanation: the operation enhances energy expenditure such that eating actually helps the person lose weight.

11 Aug 2015

Argos Therapeutics begins AGS-003 clinical trial in patients with metastatic renal cell carcinoma

Argos Therapeutics Inc., an immuno-oncology company focused on the development and commercialization of fully individualized immunotherapies for the treatment of cancer based on the Arcelis technology platform, today announced the initiation of a single-center pilot clinical trial of AGS-003 as a neoadjuvant immunotherapy in patients with localized renal cell carcinoma.

11 Aug 2015

New TSRI discovery could open way to incorporate sulfur into natural antibiotic products

In a discovery with implications for future drug design, scientists from the Florida campus of The Scripps Research Institute have shown an unprecedented mechanism for how a natural antibiotic with antitumor properties incorporates sulfur into its molecular structure, an essential ingredient of its antitumor activity.

11 Aug 2015

Sinovac Biotech releases results of 2015 Annual General Meeting of Shareholders held in Beijing, PRC

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, today announced the results of the Company's 2015 Annual General Meeting of Shareholders held on Tuesday, August 11, 2015 in Beijing, PRC.

11 Aug 2015

Scientists identify molecular partnership that may help explain how pancreatic cancer spreads

Scientists at the Johns Hopkins Kimmel Cancer Center have identified a molecular partnership in pancreatic cancer cells that might help to explain how the disease spreads — metastasizes — in some cases. Their findings reveal urgently needed new targets to treat pancreatic cancer, which strikes nearly 50,000 people in the U.S. each year and has only a 5 percent survival rate five years after diagnosis.

11 Aug 2015

GLOBVAC programme tests new vaccine that may provide complete protection against Ebola virus

The Research Council of Norway's Programme for Global Health and Vaccination Research (GLOBVAC) is co-funding testing of a new vaccine against Ebola that is drawing widespread international attention. The research programme has allocated NOK 20 million towards this work.

11 Aug 2015

Engineers can now develop virtual prototypes of complete systems using ANSYS 16.2

Using the newly released ANSYS 16.2, engineers can now create virtual prototypes of complete systems, enabling them to make significant strides in innovation and to unleash next-generation products within their industries.

11 Aug 2015

Aeterna Zentaris reports that DSMB scheduled to close second interim analysis of ZoptEC Phase 3 trial in early October

Aeterna Zentaris Inc. today announced that the independent Data and Safety Monitoring Board for the pivotal Phase 3 ZoptEC (Zoptarelin Doxorubicin in Endometrial Cancer) study with zoptarelin doxorubicin in women with advanced, recurrent or metastatic endometrial cancer, will complete a pre-specified second interim efficacy and safety analysis of the compound in early October 2015.

11 Aug 2015

ORBERA Managed Weight Loss System receives final approval from FDA

The ORBERA™ Managed Weight Loss System received its final approval on Wednesday, August 5th and Ultimate Bariatrics is proud to be one of the first in the country to offer this new tool in helping people achieve their weight loss goals. Ultimate Bariatrics is excited to share that the U.S. Food and Drug Administration has approved ORBERA, a safe and effective weight loss solution with 20 years of global experience and real world results.

11 Aug 2015

CyMedica Orthopedics secures CE Mark for QB1 Muscle Activation System

CyMedica Orthopedics, Inc. today announced that it has received a CE (Conformité Européenne) Mark for its QB1 Muscle Activation System. The product received its FDA 510(k) clearance in April 2015, and has since enjoyed a tremendous reception from orthopedic surgeons and knee patients across the United States.

11 Aug 2015

Endra photoacoustic CT preclinical imaging technology to be brought to Australia by AXT

AXT is proud to announce that they have just signed an exclusive distributorship agreement with US-based Endra Life Sciences. Endra are a developer of photoacoustic (PA) technology for bio-medical imaging and have commercialised their breakthrough technology. This new deal further bolsters AXT’s life science and preclinical imaging portfolios with another unique technology.

From MR Solutions 11 Aug 2015

New project examines links between language and perception in people with ASD

How do children and young adults with autism spectrum disorders (ASD) understand idioms and other figures of speech? A 4.15 million euro EU project based out of the Norwegian University of Science and Technology is examining the links between language and perception in autistic individuals as just one of 15 cross-disciplinary projects designed to bring a better understanding to how our perception and language interact and change over time and in individuals.

11 Aug 2015

Griffith research aims to combat tooth decay problems in Australian children

Tooth decay in children is a major problem across Australia, especially so in rural, remote and Indigenous communities. Children in the Northern Peninsula Area have a particular problem partly because the plant to add fluoride to the water system is no longer in use.

11 Aug 2015

St. Luke’s surgeons first to perform percutaneous Mitral Valve Repair using MitraClip technology

Arthur Decheser said the “doctors were dancing” last week after they successfully used a new device to stop his mitral valve from leaking.

11 Aug 2015

PHA announces keynote speakers for 16th annual Population Health Forum

The Population Health Alliance has just announced its keynote speakers for the organization's 16th annual Population Health Forum. This year's line-up includes noted journalist Eleanor Clift, political expert Mark Siegel, Director of Physician Regulatory issues for CMS Dr. William Rogers, and industry expert and Oliver Wyman Partner Sam Glick.

11 Aug 2015

VolitionRx reports net loss of $1.9 million for second quarter 2015

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, today announced financial results for the second quarter ended June 30, 2015.

11 Aug 2015

Sorrento, TNK Therapeutics to exclusively license NanoVelcro CTC assay from CytoLumina and FetoLumina

Sorrento Therapeutics, Inc. announced today that it as well as its wholly-owned subsidiary TNK Therapeutics, Inc. have entered into a binding term sheet to exclusively license the NanoVelcro Circulating Tumor Cell (CTC) profiling assay technology from CytoLumina Technologies Corp. and FetoLumina Technologies Corp., two privately-held sister biotechnology companies in Los Angeles, California.

11 Aug 2015

Marken signs agreement with OnAsset for use of advanced GPS tracking device on drug shipments

Marken, the leading clinical logistics organization (CLO), has entered into an exclusive agreement with OnAsset Intelligence Inc. for use of their most advanced GPS tracking device on key shipments. The device will significantly improve Marken's real-time, track and trace capability through custom-designed software.

11 Aug 2015

C.R. Bard agrees to pay over $200 million to settle transvaginal mesh lawsuit claims

MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, reports today that C.R. Bard Inc. has recently settled at least 3,000 cases against them, agreeing to pay more than $200 million to the women plaintiffs who were injured by the company's vaginal-mesh inserts.

11 Aug 2015

Medical News

Orthocell presents positive data for Ortho-ATI and Ortho-ACI in patients with damaged cartilage, tendon injuries

Gastric bypass surgery enhances energy expenditure, leads to sustained weight loss

Argos Therapeutics begins AGS-003 clinical trial in patients with metastatic renal cell carcinoma

New TSRI discovery could open way to incorporate sulfur into natural antibiotic products

Sinovac Biotech releases results of 2015 Annual General Meeting of Shareholders held in Beijing, PRC

Scientists identify molecular partnership that may help explain how pancreatic cancer spreads

GLOBVAC programme tests new vaccine that may provide complete protection against Ebola virus

Engineers can now develop virtual prototypes of complete systems using ANSYS 16.2

Aeterna Zentaris reports that DSMB scheduled to close second interim analysis of ZoptEC Phase 3 trial in early October

ORBERA Managed Weight Loss System receives final approval from FDA

CyMedica Orthopedics secures CE Mark for QB1 Muscle Activation System

Endra photoacoustic CT preclinical imaging technology to be brought to Australia by AXT

New project examines links between language and perception in people with ASD

Griffith research aims to combat tooth decay problems in Australian children

St. Luke’s surgeons first to perform percutaneous Mitral Valve Repair using MitraClip technology

PHA announces keynote speakers for 16th annual Population Health Forum

VolitionRx reports net loss of $1.9 million for second quarter 2015

Sorrento, TNK Therapeutics to exclusively license NanoVelcro CTC assay from CytoLumina and FetoLumina

Marken signs agreement with OnAsset for use of advanced GPS tracking device on drug shipments

C.R. Bard agrees to pay over $200 million to settle transvaginal mesh lawsuit claims

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News